Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC
CatalYm GmbH
CatalYm GmbH
The Canadian College of Naturopathic Medicine
Brigham and Women's Hospital
Korea University Guro Hospital
First Affiliated Hospital of Kunming Medical University
Peking University First Hospital
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
McGill University Health Centre/Research Institute of the McGill University Health Centre
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC
Laval University
Peking University First Hospital
Ottawa Hospital Research Institute
Peking University First Hospital
Yonsei University
Weill Medical College of Cornell University
Sun Yat-sen University
Yonsei University
Bristol-Myers Squibb
University Hospitals Bristol and Weston NHS Foundation Trust
Kaiser Permanente
Duke University
Kael-GemVax Co., Ltd.